Education
About Us
Working with TipRanks
Follow Us
Lisata Therapeutics, Inc. (DE:8NE)
:8NE
See the Price Targets and Ratings of:
8NE Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
€13.9
Buy
581.13%
Upside
Reiterated
12/11/24
Positive Outlook for Lisata Therapeutics Amid Promising Developments and Strategic Collaborations
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
€13.9
Buy
581.13%
Upside
Reiterated
12/11/24
Positive Outlook for Lisata Therapeutics Amid Promising Developments and Strategic Collaborations
8NE Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Nov 24
Dec 24
Strong Buy
5
4
4
3
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
4
4
3
3
Each month's total comprises the sum of three months' worth of ratings.
8NE Stock Forecast FAQ
What is DE:8NE’s average 12-month price target, according to analysts?
Based on analyst ratings, Lisata Therapeutics, Inc.’s 12-month average price target is €13.84.
What is DE:8NE’s upside potential, based on the analysts’ average price target?
Lisata Therapeutics, Inc. has 578.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Lisata Therapeutics, Inc. a Buy, Sell or Hold?
Lisata Therapeutics, Inc. has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lisata Therapeutics, Inc.’s share price target?
The average share price target for Lisata Therapeutics, Inc. is €13.84. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €13.84 ,and the lowest forecast is €13.84. The average share price target represents 578.53% Increase from the current price of €2.04.
The highest analyst share price target is €13.84 ,and the lowest forecast is €13.84. The average share price target represents 578.53% Increase from the current price of €2.04.
What do analysts say about Lisata Therapeutics, Inc.?
Lisata Therapeutics, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Lisata Therapeutics, Inc.?
To buy shares of DE:8NE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.